{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:59:06Z","timestamp":1790395146989,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7161011"],"award-info":[{"award-number":["7161011"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1402221"],"award-info":[{"award-number":["U1402221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573640"],"award-info":[{"award-number":["81573640"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373997"],"award-info":[{"award-number":["81373997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study","award":["BZ0150"],"award-info":[{"award-number":["BZ0150"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.intimp.2017.05.027","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T05:30:51Z","timestamp":1496640651000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome"],"prefix":"10.1016","volume":"49","author":[{"given":"Qian-hang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-he","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-7853","authenticated-orcid":false,"given":"Nai-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.05.027_bb0005","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-016-0005-1","article-title":"CRMPs function in neurons and glial cells: potential therapeutic targets for neurodegenerative diseases and CNS injury","author":"Nagai","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2017.05.027_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0020","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2017.05.027_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-016-0245-0","article-title":"Role of microglia in neurological disorders and their potentials as a therapeutic target","author":"Du","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.intimp.2017.05.027_bb0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.jcbfm.9600609","article-title":"Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?","volume":"28","author":"Trendelenburg","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"10","key":"10.1016\/j.intimp.2017.05.027_bb0035","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.2923","article-title":"Heterogeneity of CNS myeloid cells and their roles in neurodegeneration","volume":"14","author":"Prinz","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","article-title":"Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration","volume":"15","author":"Patejdl","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.1012543","article-title":"The role of inflammasome-derived IL-1 in driving IL-17 responses","volume":"93","author":"Mills","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-065X.2011.01042.x","article-title":"Deregulated inflammasome signaling in disease","volume":"243","author":"Lamkanfi","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2017.05.027_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fnins.2014.00315","article-title":"Inflammasomes in neuroinflammation and changes in brain function: a focused review","volume":"8","author":"Singhal","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2017.05.027_bb0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2017.05.027_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.it.2012.03.001","article-title":"Toll-like receptor (TLR) and inflammasome actions in the central nervous system","volume":"33","author":"Hanamsagar","year":"2012","journal-title":"Trends Immunol."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2017.05.027_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033583508004733","article-title":"Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy","volume":"41","author":"Margittai","year":"2008","journal-title":"Q. Rev. Biophys."},{"issue":"5","key":"10.1016\/j.intimp.2017.05.027_bb0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","article-title":"Disease-associated amyloid and misfolded protein aggregates activate the inflammasome","volume":"17","author":"Masters","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2017.05.027_bb0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00281-015-0485-5","article-title":"Protective and detrimental roles of inflammasomes in disease","volume":"37","author":"Saavedra","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2017.05.027_bb0090","article-title":"Inflammasome as a new therapeutic target for diabetic complications","author":"Volpe","year":"2016","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"issue":"6b","key":"10.1016\/j.intimp.2017.05.027_bb0095","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1101\/gr.1053803","article-title":"Comparative analysis of apoptosis and inflammation genes of mice and humans","volume":"13","author":"Reed","year":"2003","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","article-title":"The NLR gene family: a standard nomenclature","volume":"28","author":"Ting","year":"2008","journal-title":"Immunity"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2017.05.027_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.13217","article-title":"The pathogenic role of the inflammasome in neurodegenerative diseases","volume":"136","author":"Freeman","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2017.05.027_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fimmu.2013.00462","article-title":"Interactions between Nod-like receptors and intestinal bacteria","volume":"4","author":"de Zoete","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng1724","article-title":"Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin","volume":"38","author":"Boyden","year":"2006","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12264-013-1328-9","article-title":"Research progress on the NLRP3 inflammasome and its role in the central nervous system","volume":"29","author":"Liu","year":"2013","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clim.2008.08.011","article-title":"NLRC4\/IPAF: a CARD carrying member of the NLR family","volume":"130","author":"Sutterwala","year":"2009","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2017.05.027_bb0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cell.2014.01.026","article-title":"NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion","volume":"156","author":"Wlodarska","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2012.02.001","article-title":"An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages","volume":"36","author":"Khare","year":"2012","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/eji.201545839","article-title":"AIM2 inflammasome in infection, cancer, and autoimmunity: role in DNA sensing, inflammation, and innate immunity","volume":"46","author":"Man","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2017.05.027_bb0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"7081","key":"10.1016\/j.intimp.2017.05.027_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0170","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.4049\/jimmunol.0901323","article-title":"Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome","volume":"183","author":"Joly","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2017.05.027_bb0175","series-title":"Neutrophil P2X7 Receptors Mediate NLRP3 Inflammasome-dependent IL-1beta Secretion in Response to ATP","first-page":"10555","volume":"7","author":"Karmakar","year":"2016"},{"issue":"7293","key":"10.1016\/j.intimp.2017.05.027_bb0180","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2017.05.027_bb0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"issue":"28","key":"10.1016\/j.intimp.2017.05.027_bb0195","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.2008.00730.x","article-title":"Inflammasomes: guardians of cytosolic sanctity","volume":"227","author":"Lamkanfi","year":"2009","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"36","key":"10.1016\/j.intimp.2017.05.027_bb0210","doi-asserted-by":"crossref","first-page":"14867","DOI":"10.1073\/pnas.1111101108","article-title":"NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/039463200902200208","article-title":"Inflammasomes are differentially expressed in cardiovascular and other tissues","volume":"22","author":"Yin","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130624","article-title":"NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes","volume":"10","author":"Gustin","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.intimp.2017.05.027_bb0225","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.bbadis.2014.08.001","article-title":"Amyloid-beta(1-42) protofibrils stimulate a quantum of secreted IL-1beta despite significant intracellular IL-1beta accumulation in microglia","volume":"1842","author":"Terrill-Usery","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"issue":"258","key":"10.1016\/j.intimp.2017.05.027_bb0235","doi-asserted-by":"crossref","first-page":"pe3","DOI":"10.1126\/scisignal.2003898","article-title":"Inflammatory cytokines at the summits of pathological signal cascades in brain diseases","volume":"6","author":"Steinman","year":"2013","journal-title":"Sci. Signal"},{"issue":"8","key":"10.1016\/j.intimp.2017.05.027_bb0240","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2017.05.027_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1742-2094-10-143","article-title":"Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice","volume":"10","author":"Tanaka","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2017.05.027_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-2-15","article-title":"Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid","volume":"2","author":"Craft","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0260","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","article-title":"Toll-like receptors and chronic inflammation in rheumatic diseases: new developments","volume":"12","author":"Joosten","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2017.05.027_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-032414-112306","article-title":"Inflammasome-independent regulation of IL-1-family cytokines","volume":"33","author":"Netea","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2017.05.027_bb0275","doi-asserted-by":"crossref","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2017.05.027_bb0280","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","article-title":"Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders","volume":"20","author":"Hong","year":"2016","journal-title":"Int. Neurourol. J."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0290","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000090733","article-title":"An estimate of the worldwide prevalence and direct costs of dementia in 2003","volume":"21","author":"Wimo","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0295","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2017.05.027_bb0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03033773","article-title":"Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research","volume":"7","author":"Aguilar","year":"2005","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2011-101815","article-title":"Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology","volume":"25","author":"Morimoto","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.intimp.2017.05.027_bb0310","doi-asserted-by":"crossref","first-page":"756357","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","article-title":"Microglia and neurodegeneration: the role of systemic inflammation","volume":"61","author":"Cunningham","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0320","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajpath.2011.05.045","article-title":"MyD88 deficiency ameliorates beta-amyloidosis in an animal model of Alzheimer's disease","volume":"179","author":"Lim","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/IAI.02370-14","article-title":"Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curli","volume":"83","author":"Rapsinski","year":"2015","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0330","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"8","key":"10.1016\/j.intimp.2017.05.027_bb0335","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"issue":"7434","key":"10.1016\/j.intimp.2017.05.027_bb0340","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cns.12066","article-title":"Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe\/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2017.05.027_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-523-1_1","article-title":"Assessing beta-amyloid-induced NLRP3 inflammasome activation in primary microglia","volume":"1040","author":"Schnaars","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0355","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/eji.200940185","article-title":"Critical functions of priming and lysosomal damage for NLRP3 activation","volume":"40","author":"Hornung","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2017.05.027_bb0360","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","article-title":"NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity","volume":"69","author":"Hafner-Bratkovic","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0365","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12035-013-8475-x","article-title":"The NLRP3 inflammasome in Alzheimer's disease","volume":"48","author":"Tan","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0370","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.intimp.2017.05.027_bb0375","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.intimp.2017.05.027_bb0380","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1074\/jbc.M708362200","article-title":"Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein","volume":"283","author":"Hook","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0385","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12017-013-8274-6","article-title":"Glial uptake of amyloid beta induces NLRP3 inflammasome formation via cathepsin-dependent degradation of NLRP10","volume":"16","author":"Murphy","year":"2014","journal-title":"NeuroMolecular Med."},{"issue":"10","key":"10.1016\/j.intimp.2017.05.027_bb0390","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4161\/auto.29647","article-title":"Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome","volume":"10","author":"Cho","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2017.05.027_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exger.2014.09.014","article-title":"Parkinson's disease and age: the obvious but largely unexplored link","volume":"68","author":"Abdullah","year":"2015","journal-title":"Exp. Gerontol."},{"issue":"11","key":"10.1016\/j.intimp.2017.05.027_bb0400","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/1535370215576313","article-title":"Parkinson's disease and enhanced inflammatory response","volume":"240","author":"Stojkovska","year":"2015","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2017.05.027_bb0405","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0410","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"Pt 7","key":"10.1016\/j.intimp.2017.05.027_bb0415","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/brain\/awn101","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2017.05.027_bb0420","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnana.2015.00032","article-title":"Inflammation in Parkinson's disease: role of glucocorticoids","volume":"9","author":"Herrero","year":"2015","journal-title":"Front. Neuroanat."},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0425","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci. Res."},{"issue":"10","key":"10.1016\/j.intimp.2017.05.027_bb0430","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2017.05.027_bb0435","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","article-title":"Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?","volume":"28","author":"Olanow","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2017.05.027_bb0440","first-page":"713517","article-title":"Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease","volume":"2011","author":"Litteljohn","year":"2010","journal-title":"Park. Dis."},{"key":"10.1016\/j.intimp.2017.05.027_bb0445","doi-asserted-by":"crossref","first-page":"952375","DOI":"10.1155\/2013\/952375","article-title":"Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease","volume":"2013","author":"More","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0450","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20150617","article-title":"Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease","volume":"471","author":"Gustot","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2017.05.027_bb0455","article-title":"MicroRNA-7 enhances subventricular zone neurogenesis by inhibiting NLRP3\/caspase-1 axis in adult neural stem cells","author":"Fan","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.intimp.2017.05.027_bb0460","first-page":"282","article-title":"Seeking a mechanism for the toxicity of oligomeric alpha-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.intimp.2017.05.027_bb0465","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"25","key":"10.1016\/j.intimp.2017.05.027_bb0470","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2017.05.027_bb0475","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2017.05.027_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062143","article-title":"Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis","volume":"8","author":"Freeman","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2017.05.027_bb0485","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2013.04.016","article-title":"Inhibition of phagocytosis and lysosomal acidification suppresses neurotoxic prion peptide-induced NALP3 inflammasome activation in BV2 microglia","volume":"260","author":"Shi","year":"2013","journal-title":"J. Neuroimmunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691730200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T12:13:37Z","timestamp":1569413617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691730200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":97,"alternative-id":["S156757691730200X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.05.027","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}